DENTSPLY SIRONA

Analysts Weigh Mixed Outlook for DENTSPLY SIRONA as Valuation and Guidance Adjusted

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

03 May 25

Updated

06 Dec 25

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

-40.9%

7D

4.2%

Loading

1Y

-40.9%

7D

4.2%

You can edit this narrative until Dec 7 8:05 AM. Then, changes will post as Updates.

Author's Valuation

US$12.9610.8% undervalued

AnalystConsensusTarget Fair Value

Shared on 06 Dec 25

XRAY: New Leadership And Turnaround Plan Will Drive Long-Term Recovery Potential

DENTSPLY SIRONA’s analyst price target has been revised modestly lower to $12.96 per share from $13.00, as analysts factor in softer earnings performance, reduced guidance, and ongoing leadership transitions, despite a still constructive long term recovery narrative. Analyst Commentary Analysts are reassessing DENTSPLY SIRONA’s risk reward profile in light of weaker execution, reduced guidance, and leadership turnover, resulting in a cluster of lower price targets and more tempered expectations for the timing of any recovery.

Shared on 22 Nov 25

Fair value Decreased 19%

XRAY: Management Shifts And Revised Earnings Guidance Will Drive Long-Term Share Price Recovery

Analysts have lowered their price target for DENTSPLY SIRONA from approximately $16 to around $13. They cite weaker-than-expected earnings, reduced profit margins, and challenges with company guidance as the key factors influencing their decision.

Shared on 06 Nov 25

Fair value Decreased 1.32%

XRAY: Price Target Reductions Will Support Bullish Outlook Despite Sector Headwinds

DENTSPLY SIRONA's analyst price target has been slightly reduced, with recent updates reflecting a new target near $18 to $23. Analysts have incorporated modest changes in fair value and adjusted growth expectations following the latest quarterly results.

Shared on 22 Oct 25

Fair value Decreased 1.30%

Analysts have reduced their price target for DENTSPLY SIRONA from $20 to $18, reflecting adjustments to growth and valuation models after the company's recent quarterly results. Analyst Commentary Bullish Takeaways Bullish analysts note the company's ongoing commitment to refining its operational model, which may lead to improved efficiency over time.

Shared on 08 Oct 25

Fair value Decreased 2.54%

Analysts have slightly revised their price targets for DENTSPLY SIRONA, with some lowering expectations by as much as $2 per share. They cite ongoing end-market challenges and updated financial models following recent company results.

Shared on 10 Aug 25

Fair value Decreased 7.27%

Despite an improved revenue growth outlook, a significantly higher discount rate has outweighed this positive, leading to a reduced fair value estimate for DENTSPLY SIRONA, with the consensus analyst price target declining from $18.18 to $17.14. What's in the News Reaffirmed 2025 earnings guidance, expecting net sales of $3.60–$3.70 billion (down 4.0% to 2.0% constant currency), reflecting current tariffs and trade policy.

AnalystConsensusTarget Fair Value

US$12.96

10.8% undervalued

Future estimation in

% p.a.

0

Decrease

Increase

Current revenue growth rate

1.95%

Medical Equipment revenue growth rate

8.17%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

10.12%

Calculation

US$174.11m

Earnings '28

x

20.04x

PE Ratio '28

=

US$3.49b

Market Cap '28

US$3.49b

Market Cap '28

/

201.24m

No. shares '28

=

US$17.33

Share Price '28

US$17.33 Share Price '28

Discounted to 2025 @ 10.21% p.a.

=

US$12.95

Fair Value '25